Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Luz

1450 Paediatric Specialised Transport Teams in the Central Region of Portugal

Pediatric Research

English

Second-Site Proviral Enhancer Alterations in Lymphomas Induced by Enhancer Mutants of SL3-3 Murine Leukemia Virus: Negative Effect of Nuclear Factor 1 Binding Site.

English

Stability of AML1 (Core) Site Enhancer Mutations in T Lymphomas Induced by Attenuated SL3-3 Murine Leukemia Virus Mutants.

English

Increased Lymphomagenicity and Restored Disease Specificity of AML1 Site (Core) Mutant SL3-3 Murine Leukemia Virus by a Second-Site Enhancer Variant Evolved in Vivo.

English

Related publications

COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?

Nature Reviews Immunology

English

Sterile Inflammation: Sensing and Reacting to Damage

Nature Reviews Immunology

English

DAMP-driven Metabolic Adaptation

Nature Reviews Immunology

English

The Regulation of IL-10 Production by Immune Cells

Nature Reviews Immunology

English

Complement as a Target in COVID-19?

Nature Reviews Immunology

English

The Function of Fcγ Receptors in Dendritic Cells and Macrophages

Nature Reviews Immunology

English

Monocyte Recruitment During Infection and Inflammation

Nature Reviews Immunology

English

Signalling Pathways That Control Vertebrate Haematopoietic Stem Cell Specification

Nature Reviews Immunology

English

Heat Shock Proteins Are No DAMPs, Rather 'DAMPERs'

Nature Reviews Immunology

English

Standardization in Flow Cytometry: Correct Sample Handling as a Priority

Nature Reviews Immunology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Luz

1450 Paediatric Specialised Transport Teams in the Central Region of Portugal

Second-Site Proviral Enhancer Alterations in Lymphomas Induced by Enhancer Mutants of SL3-3 Murine Leukemia Virus: Negative Effect of Nuclear Factor 1 Binding Site.

Stability of AML1 (Core) Site Enhancer Mutations in T Lymphomas Induced by Attenuated SL3-3 Murine Leukemia Virus Mutants.

Increased Lymphomagenicity and Restored Disease Specificity of AML1 Site (Core) Mutant SL3-3 Murine Leukemia Virus by a Second-Site Enhancer Variant Evolved in Vivo.

Related publications

COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?

Sterile Inflammation: Sensing and Reacting to Damage

DAMP-driven Metabolic Adaptation

The Regulation of IL-10 Production by Immune Cells

Complement as a Target in COVID-19?

The Function of Fcγ Receptors in Dendritic Cells and Macrophages

Monocyte Recruitment During Infection and Inflammation

Signalling Pathways That Control Vertebrate Haematopoietic Stem Cell Specification

Heat Shock Proteins Are No DAMPs, Rather 'DAMPERs'

Standardization in Flow Cytometry: Correct Sample Handling as a Priority